Free Trial
CVE:SBM

Sirona Biochem (SBM) Stock Price, News & Analysis

Sirona Biochem logo
C$0.06 -0.01 (-7.69%)
As of 03/7/2025

About Sirona Biochem Stock (CVE:SBM)

Key Stats

Today's Range
C$0.06
C$0.06
50-Day Range
C$0.06
C$0.06
52-Week Range
C$0.02
C$0.10
Volume
182,010 shs
Average Volume
79,592 shs
Market Capitalization
C$15.41 million
P/E Ratio
N/A
Dividend Yield
1.50%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SBM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sirona Biochem and its competitors with MarketBeat's FREE daily newsletter.

SBM Stock News Headlines

Sirona Biochem Corp. (SBM.V) - Yahoo Finance
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal with Saudi Arabia to power its new AI empire 🤯 We’re talking about hundreds of thousands of chips, including their latest Grace Blackwell supercomputer.
Sirona Biochem Corp (SBM)
See More Headlines

SBM Stock Analysis - Frequently Asked Questions

Sirona Biochem's stock was trading at C$0.06 at the beginning of 2025. Since then, SBM stock has increased by 0.0% and is now trading at C$0.06.

Shares of SBM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that Sirona Biochem investors own include Allena Pharmaceuticals (ALNA), Ampliphi Biosciences (APHB), Apellis Pharmaceuticals (APLS), Athersys (ATHX), Iovance Biotherapeutics (IOVA), Neovasc (NVCN) and Sorrento Therapeutics (SRNE).

Industry, Sector and Symbol

Stock Exchange
CVE
Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
CVE:SBM
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
C($0.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-C$2.67 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-9,810.47%
Return on Assets
-148.11%

Debt

Debt-to-Equity Ratio
219.21
Current Ratio
0.34
Quick Ratio
2.41

Sales & Book Value

Annual Sales
C$683.77 thousand
Price / Sales
22.54
Cash Flow
C$0.00 per share
Price / Cash Flow
35.00
Book Value
C($0.01) per share
Price / Book
-6.00

Miscellaneous

Outstanding Shares
256,820,000
Free Float
N/A
Market Cap
C$15.41 million
Optionable
Not Optionable
Beta
-0.03
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (CVE:SBM) was last updated on 7/11/2025 by MarketBeat.com Staff
From Our Partners